Friday March 9, 2018 0 comments
ENGLEWOOD -- Aytu BioScience, Inc. (NASDAQ: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced it has received registration in Mexico for the MiOXSYS System.
The MiOXSYS System will be distributed exclusively through IMP Medica, a distributor of medical products to urologists, andrologists, and fertility centers throughout Mexico and in key markets in Latin America.
"Regulatory licenses and registrations are critical to our efforts of effectively penetrating these new markets,” said Josh Disbrow, Aytu’s CEO.
“MiOXSYS continues to gain traction with its international commercial expansion as regulatory bodies, like Mexico's COFEPRIS, approve the product for clinical use in the assessment of male infertility."
Mexico is one of the top 10 largest countries in the world, with a population of more than 127 million. Approximately one in six couples suffer from infertility, and almost half of these cases can be attributed to male factor infertility.
"We recently appointed IMP Medica, headquartered in Mexico City, Mexico, as exclusive distributor of the MiOXSYS System in Mexico,” Disbrow said.
“We are pleased to now be able to offer MiOXSYS to clinicians and laboratories throughout Mexico who seek to better identify and treat men with suspected infertility and for which oxidative stress may be implicated."